Michael Woudenberg
2023
In 2023, Michael Woudenberg earned a total compensation of $297.4K as Chief Operating Officer at InMed Pharmaceuticals, a 10% decrease compared to previous year.
Compensation breakdown
| Bonus | $47,924 |
|---|---|
| Option Awards | $9,878 |
| Salary | $239,619 |
| Total | $297,421 |
Woudenberg received $239.6K in salary, accounting for 81% of the total pay in 2023.
Woudenberg also received $47.9K in bonus and $9.9K in option awards.
Rankings
In 2023, Michael Woudenberg's compensation ranked 2,545th out of 3,006 executives tracked by ExecPay. In other words, Woudenberg earned more than 15.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,545 out of 3,006 | 15th |
Division Manufacturing | 1,422 out of 1,650 | 14th |
Major group Chemicals And Allied Products | 821 out of 918 | 11th |
Industry group Drugs | 801 out of 881 | 9th |
Industry Pharmaceutical Preparations | 574 out of 637 | 10th |
Source: SEC filing on October 27, 2023.
Woudenberg's colleagues
We found four more compensation records of executives who worked with Michael Woudenberg at InMed Pharmaceuticals in 2023.
2023
Eric Adams
InMed Pharmaceuticals
Chief Executive Officer
2023
Alexandra Mancini
InMed Pharmaceuticals
Senior Vice President, Clinical & Regulatory Affairs
2023
Eric Hsu
InMed Pharmaceuticals
Senior Vice President, Preclinical Research & Development
2023
Jonathan Tegge
InMed Pharmaceuticals